Valuation Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE Other stock markets 01:30:02 12/06/2026 am IST			5-day change	1st Jan Change
292.44 ^USD	+0.49%		-4.89%	-3.48%

03/06	Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM
19/05	Bio-Rad Laboratories, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 08:30 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,439	12,460	9,399	9,182	8,212	7,885	-	-
Change	-	-44.47%	-24.57%	-2.31%	-10.57%	-3.98%	-	-
Enterprise Value (EV) ¹	22,439	11,868	8,992	8,730	7,874	7,136	6,920	6,779
Change	-	-47.11%	-24.24%	-2.91%	-9.8%	-9.37%	-3.03%	-2.04%
P/E Ratio	5.38x	-	-14.8x	-5.03x	10.9x	35.1x	34.4x	34.6x
PBR	-	1.27x	1.05x	1.41x	1.11x	1.13x	1.09x	-
PEG	-	-	-	-0x	-0x	-0.5x	15.06x	-49.07x
Capitalization / Revenue	7.68x	4.45x	3.52x	3.58x	3.18x	3.07x	2.99x	2.95x
EV / Revenue	7.68x	4.24x	3.37x	3.4x	3.05x	2.78x	2.63x	2.53x
EV / EBITDA	33.1x	17.8x	16.8x	18.2x	17.4x	17.9x	16.2x	15.3x
EV / EBIT	39.3x	22.7x	23.7x	26.4x	25.3x	26.8x	23.2x	21.1x
EV / FCF	41.9x	127x	24x	-	-	22.9x	22.1x	20.8x
FCF Yield	2.39%	0.79%	4.17%	-	-	4.37%	4.53%	4.81%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	140.6	-	-21.82	-65.36	27.85	8.32	8.51	8.45
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,923	2,802	2,671	2,566	2,583	2,567	2,635	2,676
EBITDA ¹	677.5	667.9	535.9	479.5	453.2	398.6	426.3	442.3
EBIT ¹	571.2	524	378.9	331.3	311.6	266.8	298	322
Net income ¹	4,246	-3,628	-637.3	-1,844	759.9	224.8	229.7	228.3
Net Debt ¹	-	-592.5	-407.6	-452.1	-337.7	-749	-965.4	-1,107
Reference price ²	755.57	420.49	322.89	328.51	302.99	292.44	292.44	292.44
Nbr of stocks (in thousands)	29,918	29,824	29,145	27,997	26,975	26,762	-	-
Announcement Date	10/02/22	16/02/23	15/02/24	13/02/25	12/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
BIO-RAD LABORATORIES, INC.	35.15x	2.78x	17.91x	-.--%	788.54Cr
ABBOTT LABORATORIES	22.55x	3.34x	12.55x	2.84%	16TCr
MEDTRONIC PLC	20.19x	3.49x	12.53x	3.56%	10TCr
CENCORA, INC.	14.83x	0.18x	11.12x	0.84%	5.48TCr
HOYA CORPORATION	34.95x	8.63x	23.22x	1.1%	5.35TCr
BECTON, DICKINSON AND COMPANY	36.72x	2.94x	10.1x	2.62%	4.06TCr
MEDLINE INC.	35.54x	1.31x	11.57x	0.22%	3.14TCr
DEXCOM, INC.	30.74x	5.49x	17.51x	-.--%	2.9TCr
WEST PHARMACEUTICAL SERVICES, INC.	39.23x	6.78x	24.48x	0.27%	2.33TCr
TERUMO CORPORATION	24.42x	3.11x	12.7x	1.32%	2.08TCr
Average	29.43x	3.80x	15.37x	1.28%	5.21TCr
Weighted average by Cap.	25.90x	3.68x	14.14x	2.04%